PHGDH and glioblastoma: It was also demonstrated that PHGDH-mediated endothelial cell (EC) metabolism promotes hypoxia and immunosuppression in the tumor microenvironment, leading to glioblastoma (GBM) resistance to chimeric antigen receptor T-cell (CAR-T) cellular immunotherapy (19).